Bicycle Therapeutics financials at a glance

+ Portfolio

The revenue of Bicycle Therapeutics is reported as 0.02698 billion Dollars in the fiscal year 2023. The earnings were -5.08 Dollars per share in 2023, which was 33.68 lower than 2022. And about -0.06356 billion Dollars are reported as free cash flow in the financials of Bicycle Therapeutics 2023. No dividends were paid to the shareholders of the Bicycle Therapeutics stock NasdaqGS:BCYC in the financial year 2023.

$26.98M

Revenue

$-5.08

Earnings Per Share

0.00%

Gross Margin %

$-,172.85M

Free Cash Flow

Revenue

26.98

Earnings Per Share

-5.08

Gross Margin %

0.00

Free Cash Flow

-,172.85

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018
Rev.	Revenue	N/A	$26.98M	$14.46M	$11.70M	$10.39M	$13.80M	$7.14M
GM %	Gross Margin %	0.00%	0.00%	0.00%	-,283.69%	-,219.05%	-85.06%	-,190.93%
OM	Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-,190.56%	0.00%
EPS	Earnings Per Share	$-4.99	$-5.08	$-3.80	$-2.67	$-2.66	$-2.77	$-49.78
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	0	0	0	0
Sha.	Shares	N/AM	42.59M	30.02M	29.6M	23.09M	17.99M	0.84M
OCF	Operating Cash Flow	N/A	$-60.63M	$-86.11M	$-14.79M	$-17.79M	$-28.61M	$0.00M
FCF	Free Cash Flow	N/A	$-,172.85M	$-,105.10M	$-16.82M	$-18.99M	$-30.17M	$0.00M
FCFS	Free Cash Flow Per Share	$-1.48	$-1.79	$-3.54	$-0.67	$-0.99	$-2.73	$-62.12

Bicycle Therapeutics financials at a glance

Financials

Discover